BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33810275)

  • 21. Bacterial pathogens activate plasminogen to breach tissue barriers and escape from innate immunity.
    Peetermans M; Vanassche T; Liesenborghs L; Lijnen RH; Verhamme P
    Crit Rev Microbiol; 2016 Nov; 42(6):866-82. PubMed ID: 26485450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines.
    Pontecorvi P; Banki MA; Zampieri C; Zalfa C; Azmoon P; Kounnas MZ; Marchese C; Gonias SL; Mantuano E
    J Neuroinflammation; 2019 Dec; 16(1):257. PubMed ID: 31810478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
    Suenson E; Lützen O; Thorsen S
    Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Herpesviruses enhance fibrin clot lysis.
    Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
    Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin.
    Sakharov DV; Lijnen HR; Rijken DC
    J Biol Chem; 1996 Nov; 271(44):27912-8. PubMed ID: 8910391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parasitism in optima forma: exploiting the host fibrinolytic system for invasion.
    Figuera L; Gómez-Arreaza A; Avilán L
    Acta Trop; 2013 Oct; 128(1):116-23. PubMed ID: 23850506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinolytic cross-talk: a new mechanism for plasmin formation.
    Dejouvencel T; Doeuvre L; Lacroix R; Plawinski L; Dignat-George F; Lijnen HR; Anglés-Cano E
    Blood; 2010 Mar; 115(10):2048-56. PubMed ID: 19996088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
    Sakai M; Watanuki M; Matsuo O
    Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The fibrinolytic system in man.
    Collen D; Lijnen HR
    Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fibrinolytic mechanism of defibrotide: effect of defibrotide on plasmin activity.
    Echart CL; Graziadio B; Somaini S; Ferro LI; Richardson PG; Fareed J; Iacobelli M
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):627-34. PubMed ID: 19809307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolysis at the fluid-solid interface of thrombi.
    Kolev K; Longstaff C; Machovich R
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Oct; 3(4):341-55. PubMed ID: 16250865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annexin II: a plasminogen-plasminogen activator co-receptor.
    Kim J; Hajjar KA
    Front Biosci; 2002 Feb; 7():d341-8. PubMed ID: 11815288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
    Angles-Cano E; Rouy D; Lijnen HR
    Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
    Carr ME; Alving BM
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):567-73. PubMed ID: 7578900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
    Cassels R; Fears R; Smith RA
    Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasminogen: an enigmatic zymogen.
    Keragala CB; Medcalf RL
    Blood; 2021 May; 137(21):2881-2889. PubMed ID: 33735914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.